annual interest expense:
$1.38B+$550.76M(+66.49%)Summary
- As of today (May 29, 2025), TAK annual interest expense is $1.38 billion, with the most recent change of +$550.76 million (+66.49%) on March 1, 2025.
- During the last 3 years, TAK annual interest expense has risen by +$288.55 million (+26.46%).
- TAK annual interest expense is now at all-time high.
Performance
TAK Interest expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly interest expense:
$330.02M+$122.88M(+59.32%)Summary
- As of today (May 29, 2025), TAK quarterly interest expense is $330.02 million, with the most recent change of +$122.88 million (+59.32%) on March 1, 2025.
- Over the past year, TAK quarterly interest expense has increased by +$687.99 million (+192.19%).
- TAK quarterly interest expense is now -49.17% below its all-time high of $649.27 million, reached on June 30, 2021.
Performance
TAK quarterly interest expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM interest expense:
$1.38B+$687.99M(+99.28%)Summary
- As of today (May 29, 2025), TAK TTM interest expense is $1.38 billion, with the most recent change of +$687.99 million (+99.28%) on March 1, 2025.
- Over the past year, TAK TTM interest expense has increased by +$452.22 million (+48.69%).
- TAK TTM interest expense is now -26.05% below its all-time high of $1.87 billion, reached on December 31, 2020.
Performance
TAK TTM interest expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Interest expense Formula
Interest Expense = Carrying Value of Debt X Effective Interest Rate
TAK Interest expense Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +66.5% | +192.2% | +48.7% |
| 3 y3 years | +26.5% | +281.6% | +11.5% |
| 5 y5 years | +0.6% | +43.5% | -10.8% |
TAK Interest expense Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +66.5% | -41.7% | +192.2% | at high | +99.3% |
| 5 y | 5-year | at high | +66.5% | -49.2% | +182.1% | -26.1% | +99.3% |
| alltime | all time | at high | >+9999.0% | -49.2% | +182.1% | -26.1% | >+9999.0% |
TAK Interest expense History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | $1.38B(+66.5%) | $330.02M(+59.3%) | $1.38B(+99.3%) |
| Dec 2024 | - | $207.15M(-55.1%) | $692.95M(-26.0%) |
| Sep 2024 | - | $460.86M(+20.4%) | $936.64M(+6.7%) |
| Jun 2024 | - | $382.91M(-207.0%) | $877.47M(-5.5%) |
| Mar 2024 | $828.36M(-4.4%) | -$357.96M(-179.4%) | $928.72M(-23.4%) |
| Dec 2023 | - | $450.84M(+12.2%) | $1.21B(-8.7%) |
| Sep 2023 | - | $401.69M(-7.5%) | $1.33B(+0.9%) |
| Jun 2023 | - | $434.16M(-685.6%) | $1.32B(+0.5%) |
| Mar 2023 | $866.26M(-20.6%) | -$74.13M(-113.1%) | $1.31B(+9.0%) |
| Dec 2022 | - | $565.67M(+45.2%) | $1.20B(+14.8%) |
| Sep 2022 | - | $389.47M(-9.0%) | $1.05B(+2.8%) |
| Jun 2022 | - | $428.09M(-335.6%) | $1.02B(-17.9%) |
| Mar 2022 | $1.09B(-11.6%) | -$181.69M(-144.2%) | $1.24B(+21.6%) |
| Dec 2021 | - | $410.86M(+14.0%) | $1.02B(-15.7%) |
| Sep 2021 | - | $360.47M(-44.5%) | $1.21B(-16.7%) |
| Jun 2021 | - | $649.27M(-261.5%) | $1.45B(+17.3%) |
| Mar 2021 | $1.23B(-10.0%) | -$402.07M(-167.0%) | $1.24B(-33.9%) |
| Dec 2020 | - | $600.04M(-0.3%) | $1.87B(+11.8%) |
| Sep 2020 | - | $601.85M(+38.3%) | $1.67B(+6.8%) |
| Jun 2020 | - | $435.33M(+89.2%) | $1.56B(+1.0%) |
| Mar 2020 | $1.37B(+215.6%) | $230.07M(-42.8%) | $1.55B(+12.3%) |
| Dec 2019 | - | $402.22M(-18.9%) | $1.38B(+17.4%) |
| Sep 2019 | - | $496.03M(+18.4%) | $1.17B(+54.6%) |
| Jun 2019 | - | $419.11M(+595.1%) | $758.71M(+59.6%) |
| Mar 2019 | $434.39M(+379.6%) | $60.30M(-69.5%) | $475.24M(+59.7%) |
| Dec 2018 | - | $197.58M(+141.8%) | $297.55M(+86.0%) |
| Sep 2018 | - | $81.72M(-39.7%) | $159.98M(+20.7%) |
| Jun 2018 | - | $135.64M(-215.5%) | $132.52M(+53.1%) |
| Mar 2018 | $90.58M(+29.6%) | -$117.39M(-295.6%) | $86.56M(-28.4%) |
| Dec 2017 | - | $60.01M(+10.6%) | $120.84M(+5.3%) |
| Sep 2017 | - | $54.27M(-39.5%) | $114.80M(-1.6%) |
| Jun 2017 | - | $89.68M(-207.9%) | $116.70M(+52.0%) |
| Mar 2017 | $69.91M(-73.7%) | -$83.11M(-254.0%) | $76.76M(-55.3%) |
| Dec 2016 | - | $53.96M(-3.9%) | $171.62M(-7.6%) |
| Sep 2016 | - | $56.17M(+12.9%) | $185.66M(-29.9%) |
| Jun 2016 | - | $49.74M(+323.3%) | $264.69M(+0.7%) |
| Mar 2016 | $266.09M | $11.75M(-82.7%) | $262.75M(-10.7%) |
| Dec 2015 | - | $68.00M(-49.7%) | $294.30M(-13.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2015 | - | $135.20M(+182.8%) | $339.88M(+28.9%) |
| Jun 2015 | - | $47.81M(+10.4%) | $263.77M(-12.1%) |
| Mar 2015 | $300.65M(-2.0%) | $43.30M(-61.9%) | $300.03M(-20.0%) |
| Dec 2014 | - | $113.58M(+92.2%) | $374.81M(+16.0%) |
| Sep 2014 | - | $59.08M(-29.7%) | $323.13M(-3.8%) |
| Jun 2014 | - | $84.07M(-28.8%) | $335.98M(+10.2%) |
| Mar 2014 | $306.72M(+23.9%) | $118.08M(+90.8%) | $305.02M(-20.7%) |
| Dec 2013 | - | $61.90M(-14.0%) | $384.42M(+16.0%) |
| Sep 2013 | - | $71.93M(+35.4%) | $331.39M(+23.1%) |
| Jun 2013 | - | $53.11M(-73.1%) | $269.22M(+19.2%) |
| Mar 2013 | $247.51M(+937.5%) | $197.49M(+2127.1%) | $225.85M(+501.6%) |
| Dec 2012 | - | $8.87M(-9.1%) | $37.54M(+5.0%) |
| Sep 2012 | - | $9.75M(+0.1%) | $35.77M(+17.6%) |
| Jun 2012 | - | $9.74M(+6.2%) | $30.41M(+27.2%) |
| Mar 2012 | $23.86M(+53.9%) | $9.18M(+29.4%) | $23.92M(+22.0%) |
| Dec 2011 | - | $7.09M(+61.2%) | $19.61M(+24.3%) |
| Sep 2011 | - | $4.40M(+35.4%) | $15.77M(+1.4%) |
| Jun 2011 | - | $3.25M(-33.2%) | $15.55M(-0.6%) |
| Mar 2011 | $15.50M(+0.7%) | $4.86M(+49.3%) | $15.63M(+14.5%) |
| Dec 2010 | - | $3.26M(-22.0%) | $13.66M(-4.2%) |
| Sep 2010 | - | $4.18M(+25.2%) | $14.26M(-6.2%) |
| Jun 2010 | - | $3.34M(+15.6%) | $15.21M(-1.1%) |
| Mar 2010 | $15.40M(-5.5%) | $2.89M(-25.3%) | $15.38M(-5.8%) |
| Dec 2009 | - | $3.86M(-24.6%) | $16.34M(+11.2%) |
| Sep 2009 | - | $5.12M(+46.0%) | $14.69M(-6.9%) |
| Jun 2009 | - | $3.51M(-8.5%) | $15.79M(+28.6%) |
| Mar 2009 | $16.30M(+457.9%) | $3.84M(+73.2%) | $12.27M(+45.5%) |
| Dec 2008 | - | $2.22M(-64.4%) | $8.44M(+35.6%) |
| Sep 2008 | - | $6.22M | $6.22M |
| Mar 2008 | $2.92M(+38.3%) | - | - |
| Mar 2007 | $2.11M(-34.5%) | - | - |
| Mar 2006 | $3.23M(+3.7%) | - | - |
| Mar 2005 | $3.11M(-2.3%) | - | - |
| Mar 2004 | $3.19M(-7.7%) | - | - |
| Mar 2003 | $3.45M(-43.2%) | - | - |
| Mar 2002 | $6.08M(-34.2%) | - | - |
| Mar 2001 | $9.24M(-14.1%) | - | - |
| Mar 2000 | $10.77M | - | - |
FAQ
- What is Takeda Pharmaceutical Company Limited annual interest expense?
- What is the all time high annual interest expense for Takeda Pharmaceutical Company Limited?
- What is Takeda Pharmaceutical Company Limited annual interest expense year-on-year change?
- What is Takeda Pharmaceutical Company Limited quarterly interest expense?
- What is the all time high quarterly interest expense for Takeda Pharmaceutical Company Limited?
- What is Takeda Pharmaceutical Company Limited quarterly interest expense year-on-year change?
- What is Takeda Pharmaceutical Company Limited TTM interest expense?
- What is the all time high TTM interest expense for Takeda Pharmaceutical Company Limited?
- What is Takeda Pharmaceutical Company Limited TTM interest expense year-on-year change?
What is Takeda Pharmaceutical Company Limited annual interest expense?
The current annual interest expense of TAK is $1.38B
What is the all time high annual interest expense for Takeda Pharmaceutical Company Limited?
Takeda Pharmaceutical Company Limited all-time high annual interest expense is $1.38B
What is Takeda Pharmaceutical Company Limited annual interest expense year-on-year change?
Over the past year, TAK annual interest expense has changed by +$550.76M (+66.49%)
What is Takeda Pharmaceutical Company Limited quarterly interest expense?
The current quarterly interest expense of TAK is $330.02M
What is the all time high quarterly interest expense for Takeda Pharmaceutical Company Limited?
Takeda Pharmaceutical Company Limited all-time high quarterly interest expense is $649.27M
What is Takeda Pharmaceutical Company Limited quarterly interest expense year-on-year change?
Over the past year, TAK quarterly interest expense has changed by +$687.99M (+192.19%)
What is Takeda Pharmaceutical Company Limited TTM interest expense?
The current TTM interest expense of TAK is $1.38B
What is the all time high TTM interest expense for Takeda Pharmaceutical Company Limited?
Takeda Pharmaceutical Company Limited all-time high TTM interest expense is $1.87B
What is Takeda Pharmaceutical Company Limited TTM interest expense year-on-year change?
Over the past year, TAK TTM interest expense has changed by +$452.22M (+48.69%)